RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD K75.4ORPHA:2137AIH

Autoimmune Hepatitis

Autoimmune hepatitis is a rare long-term liver condition in which the immune system attacks the person's own liver cells, causing inflammation that can lead to scarring if untreated. Symptoms may include tiredness, joint aches, nausea and jaundice, though some people have none at first. Treatment usually involves steroids and other immune-suppressing medicines, with regular monitoring of liver blood tests.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

498
Articles
40
Trials (1 AU)
Data refreshed
19 October 2026
Loading...

Common Questions

What is Autoimmune Hepatitis?

Autoimmune hepatitis is a rare long-term liver condition in which the immune system attacks the person's own liver cells, causing inflammation that can lead to scarring if untreated. Symptoms may include tiredness, joint aches, nausea and jaundice, though some people have none at first. Treatment usually involves steroids and other immune-suppressing medicines, with regular monitoring of liver blood tests.

How many clinical trials are available for Autoimmune Hepatitis?

RareWays currently indexes 40 clinical trials for Autoimmune Hepatitis, of which 5 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Autoimmune Hepatitis come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Autoimmune Hepatitis.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.